Revenue Increased 17% Quarter over Quarter Operating Loss Decreased 27% Management to Host Conference Call Today at 5:00 pm ET LITTLETON, Colo., Nov. 14, 2024 (GLOBE NEWSWIRE) -- . (“Vivos” or the ...

Completed dosing of 115 participants in a bioavailability and bioequivalence (BA/BE) clinical trial in Australia for IHL-42X, an investigational treatment for obstructive sleep apnea in July 2024.

As we age, our sleep needs and habits change. While we tend to sleep more in our younger years, this gradually decreases as ...

"If you have obstructive sleep apnea, yes, this can be very dangerous." "There is limited evidence on the benefits of mouth taping and I would be very careful — and even talk to your health care ...

Other health complications arising from metabolic syndrome include obstructive sleep apnea, due to the impact of excess ...

Data for tirzepatide, the chemical compound Lilly sells as Mounjaro and Zepbound, has separately showed the blockbuster ...

An established association also exists between periodontitis and obstructive sleep apnea, although the data remain ...

LITTLETON, Colo., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development ...